Pfizer
NSE: PFIZER · ISIN INE182A01018 · Healthcare
₹3,917.70+13.90 (+0.36%)
Monday 9 November, 13:14 IST. Delayed. Source: Yahoo Finance.
Price chart
₹3,917.70 +13.90 (+0.36%) today
The day
- Previous close
- ₹3,903.80
- Open
- ₹3,900.00
- Day high
- ₹3,959.00
- Day low
- ₹3,869.00
Listed on NSE since 28 April 1999.
Key numbers
- Market value
- ₹17,945 Cr
- P/E (trailing)
- 23.85
- EPS (trailing)
- ₹164.45
- Price to book
- 4.09
- Dividend yield
- 1.92%
- Return on equity
- 20.9%
- Debt to equity
- 0.04
- Profit margin
- 32.4%
- Beta
- 0.16
- Volume today
- 26,705
- Average volume
- 54,125
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹2,422.32 Cr | ₹623.93 Cr |
| FY24 | ₹2,192.69 Cr | ₹551.33 Cr |
| FY25 | ₹2,281.00 Cr | ₹767.60 Cr |
| FY26 | ₹2,519.27 Cr | ₹722.43 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹727 Cr | ₹313 Cr | +65.7% |
| Q1 FY27Apr–Jun 2026 | ₹653 Cr | ₹204 Cr | +6.6% |
| Q4 FY26Jan–Mar 2026Audited | ₹629 Cr | ₹200 Cr | −39.6% |
| Q3 FY26Oct–Dec 2025 | ₹645 Cr | ₹142 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹642 Cr | ₹189 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹603 Cr | ₹192 Cr | – |
Source: Pfizer’s results filed with NSE, standalone (the company alone). Net profit is the share of Pfizer’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹299 Cr | ₹156 Cr |
| Inventories | ₹442 Cr | ₹473 Cr |
| Owed by customers | ₹241 Cr | ₹182 Cr |
| Cash and equivalents | ₹93 Cr | ₹103 Cr |
| Total assets | ₹5,293 Cr | ₹4,922 Cr |
| Borrowings | ₹3 Cr | ₹3 Cr |
| Total liabilities | ₹908 Cr | ₹719 Cr |
| Shareholders’ equity | ₹4,385 Cr | ₹4,203 Cr |
Source: Pfizer’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.
About Pfizer
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers therapy area and products, such as vaccines, injectables and anti-infectives, inflammation and immunology, and internal medicine for cardiovascular care, oncology, respiratory, multivitamins and multimineral, neuroscience, women's health, gastroenterology, pain management, and nutrition, addressing. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.
- Industry
- Drug Manufacturers - General
- Based in
- Mumbai
- Employees
- 1,244
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Pfizer in the last day or two.
Dividends and corporate actions
All companies- Dividend - Rs 75 Per Share
Dividend · ex-date 17 July 2026
- Dividend - Rs 35 Per Share & Special Dividend Of Rs 100 Per Share/ Special Dividend Of Rs 30
Dividend · ex-date 9 July 2025
- Dividend - Rs 35 Per Share
Dividend · ex-date 21 August 2024
- Dividend - Rs 35 Per Share/ Special Dividend - Rs 5 Per Share
Dividend · ex-date 11 August 2023
- Special Dividend - Rs 30 Per Share
Dividend · ex-date 19 September 2022 · record date 20 September 2022
- Dividend - Rs 35 Per Share
Dividend · ex-date 18 August 2022 · record date 19 August 2022
- Annual General Meeting/Dividend - Rs 30 Per Share/Special Dividend - Rs 5 Per Share
Dividend · ex-date 11 August 2021
- Annual General Meeting/Dividend - Rs 10 Per Share
Dividend · ex-date 27 August 2020
Source: NSE. Latest first, 8 of 20.
Information only, not investment advice. Prices are delayed.